{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:40Z","timestamp":1793946520232,"version":"4.8.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejso.2023.107279","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T16:12:50Z","timestamp":1700496770000},"page":"107279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Meta-analysis of prognostic factors for overall survival and disease-free survival among resected patients with combined hepatocellular carcinoma and cholangiocarcinoma"],"prefix":"10.1016","volume":"50","author":[{"given":"Tian-Run","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Jie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Wen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-9614","authenticated-orcid":false,"given":"Fu-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO;2-Z","article-title":"Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study","volume":"55","author":"Goodman","year":"1985","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2023.107279_bib2","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/cncr.10392","article-title":"Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors","volume":"94","author":"Jarnagin","year":"2002","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2023.107279_bib3","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1742-1241.2007.01694.x","article-title":"Management of combined hepatocellular and cholangiocarcinoma","volume":"62","author":"Kassahun","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ejso.2023.107279_bib4","article-title":"Outcome of combined hepatocellular and cholangiocarcinoma of the liver","volume":"2010","author":"Wang","year":"2010","journal-title":"J.\u00a0Oncol"},{"issue":"38","key":"10.1016\/j.ejso.2023.107279_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017102","article-title":"Combined hepatocellular-cholangiocarcinoma: an analysis of clinicopathological characteristics after surgery","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.ejso.2023.107279_bib6","first-page":"647","article-title":"Combined liver cell and bile duct carcinoma","volume":"25","author":"Allen","year":"1949","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1499-3872(14)60275-7","article-title":"Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery","volume":"13","author":"Lee","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int : HBPD INT."},{"issue":"9","key":"10.1016\/j.ejso.2023.107279_bib8","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1245\/s10434-012-2328-0","article-title":"Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis","volume":"19","author":"Yin","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib9","first-page":"1106","article-title":"Surgical treatment of combined hepatocellular-cholangiocarcinoma is as effective in elderly patients as it is in younger patients: a propensity score matching analysis","volume":"9","author":"Tao","year":"2018","journal-title":"J\u00a0Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2023.107279_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1245\/s10434-008-0278-3","article-title":"Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma","volume":"16","author":"Kim","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.29789","article-title":"cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation","volume":"68","author":"Brunt","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2023.107279_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.12659\/AOT.900779","article-title":"Living donor liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: experience of a single center","volume":"22","author":"Chang","year":"2017","journal-title":"Ann Transplant"},{"issue":"7","key":"10.1016\/j.ejso.2023.107279_bib13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/lt.25786","article-title":"Resection of mixed hepatocellular-cholangiocarcinoma, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma. Liver transplantation : official publication of the American association for the study of liver diseases and the","volume":"26","author":"Holzner","year":"2020","journal-title":"Internat. Liver Transplantation Soc."},{"issue":"8","key":"10.1016\/j.ejso.2023.107279_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ejso.2014.04.016","article-title":"Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma","volume":"40","author":"Kim","year":"2014","journal-title":"Eur J Surg Oncol : J. European Soc. Surgical Oncology British Assoc. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MCG.0b013e3181ce5dfa","article-title":"Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma","volume":"45","author":"Lee","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"10","key":"10.1016\/j.ejso.2023.107279_bib16","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s00595-006-3276-8","article-title":"Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"36","author":"Lee","year":"2006","journal-title":"Surg Today"},{"issue":"3","key":"10.1016\/j.ejso.2023.107279_bib17","first-page":"364","article-title":"Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma","volume":"30","author":"Li","year":"2018","journal-title":"Chinese journal of cancer research\u00a0= Chung-kuo yen cheng yen chiu"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12876-020-01586-4","article-title":"Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"10.1016\/j.ejso.2023.107279_bib19","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/lt.22307","article-title":"Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma","volume":"17","author":"Sapisochin","year":"2011","journal-title":"Liver Transplant : official publ Am Association StudLive r Diseases Int Liver Transplantation Soc"},{"key":"10.1016\/j.ejso.2023.107279_bib20","unstructured":"!!! Invalid citation !!! { }."},{"issue":"7","key":"10.1016\/j.ejso.2023.107279_bib21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.gassur.2006.01.018","article-title":"Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma","volume":"10","author":"Tang","year":"2006","journal-title":"J\u00a0Gastrointest Surg : official J Soc Surg Alimentary Tract"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7150\/ijms.50883","article-title":"The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: a propensity score matching analysis","volume":"18","author":"Tang","year":"2021","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hpb.2015.10.001","article-title":"Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database","volume":"18","author":"Vilchez","year":"2016","journal-title":"HPB : Official J Int Hepato Pancreato Biliary Assoc"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jjco\/hyg056","article-title":"Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases","volume":"33","author":"Yano","year":"2003","journal-title":"Jpn J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2023.107279_bib25","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1245\/s10434-012-2328-0","article-title":"Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis","volume":"19","author":"Yin","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107279_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11605-015-3045-3","article-title":"Postresection outcomes of combined hepatocellular carcinoma-cholangiocarcinoma, hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"20","author":"Yoon","year":"2016","journal-title":"J\u00a0Gastrointest Surg : official J Soc Surg Alimentary Tract"},{"issue":"4","key":"10.1016\/j.ejso.2023.107279_bib27","first-page":"356","article-title":"Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma","volume":"39","author":"Zhang","year":"2020","journal-title":"Ultrasonography (Seoul, Korea)"},{"issue":"2","key":"10.1016\/j.ejso.2023.107279_bib28","first-page":"161","article-title":"Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma","volume":"6","author":"Zuo","year":"2007","journal-title":"Hepatobiliary Pancreat Dis Int : HBPD INT."},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/archsurg.138.1.86","article-title":"Hepatic resection for combined hepatocellular and cholangiocarcinoma","volume":"138","author":"Liu","year":"2003","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1440-1746.1998.tb00542.x","article-title":"Combined hepatocellular-cholangiocarcinoma: a clinicopathological study","volume":"13","author":"Ng","year":"1998","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.ejso.2023.107279_bib31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3349\/ymj.2011.52.5.753","article-title":"Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea","volume":"52","author":"Park","year":"2011","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000503719","article-title":"Surgical treatment of hepatocholangiocarcinoma: a systematic review","volume":"9","author":"Gentile","year":"2020","journal-title":"Liver Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib33","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2023.107279_bib34","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ejso.2014.04.016","article-title":"Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma","volume":"40","author":"Kim","year":"2014","journal-title":"Eur J Surg Oncol : J. European Soc. Surgical Oncology British Assoc. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.ejso.2023.107279_bib35","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s00595-006-3276-8","article-title":"Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"36","author":"Lee","year":"2006","journal-title":"Surg Today"},{"issue":"10","key":"10.1016\/j.ejso.2023.107279_bib36","doi-asserted-by":"crossref","first-page":"e1774","DOI":"10.1002\/onco.13893","article-title":"Long-term survival of combined hepatocellular-cholangiocarcinoma: a nationwide study","volume":"26","author":"Chen","year":"2021","journal-title":"Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7150\/ijms.50883","article-title":"The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: a propensity score matching analysis","volume":"18","author":"Tang","year":"2021","journal-title":"Int J Med Sci"},{"issue":"2","key":"10.1016\/j.ejso.2023.107279_bib38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cam4.4448","article-title":"Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery","volume":"11","author":"Hou","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejso.2023.107279_bib39","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ (Clinical research ed)"},{"issue":"3","key":"10.1016\/j.ejso.2023.107279_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5271\/sjweh.1239","article-title":"Moose Consort Strobe and Miame Stard Remark or how can we improve the quality of reporting studies","volume":"34","author":"Verbeek","year":"2008","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.ejso.2023.107279_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.ejso.2023.107279_bib42","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ (Clinical research ed)"},{"issue":"11","key":"10.1016\/j.ejso.2023.107279_bib43","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7109","key":"10.1016\/j.ejso.2023.107279_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical research ed)"},{"issue":"3","key":"10.1016\/j.ejso.2023.107279_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.humpath.2005.08.019","article-title":"Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma","volume":"37","author":"Aishima","year":"2006","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib46","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1499-3872(14)60275-7","article-title":"Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery","volume":"13","author":"Lee","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int : HBPD INT."},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib47","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/s12885-020-07138-z","article-title":"Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jmri.25568","article-title":"Combined hepatocellular-cholangiocarcinoma: gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis","volume":"46","author":"Park","year":"2017","journal-title":"J\u00a0Magn Reson Imag : JMRI"},{"key":"10.1016\/j.ejso.2023.107279_bib49","article-title":"Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: a propensity score matched study","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"issue":"41","key":"10.1016\/j.ejso.2023.107279_bib50","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.3748\/wjg.v28.i41.5968","article-title":"Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: a retrospective multicenter cohort study","volume":"28","author":"Zhang","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00330-021-08188-y","article-title":"Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis","volume":"32","author":"Zhou","year":"2022","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib52","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/liv.14813","article-title":"Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinoma","volume":"41","author":"Kim","year":"2021","journal-title":"Liver Int : Offi J Int Assoc Study Liver"},{"issue":"9","key":"10.1016\/j.ejso.2023.107279_bib53","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.14309\/ajg.0000000000000326","article-title":"Combined hepatocellular cholangiocarcinoma: a population-based retrospective study","volume":"114","author":"Ramai","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107279_bib54","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/cam4.4474","article-title":"Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: a SEER population-based cohort study","volume":"11","author":"Yang","year":"2022","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.ejso.2023.107279_bib55","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.ejso.2022.01.023","article-title":"Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: a nomogram development based on SEER database and validation in multicenter study","volume":"48","author":"Zhou","year":"2022","journal-title":"Eur J Surg Oncol : J. European Soc. Surgical Oncology British Assoc. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ejso.2023.107279_bib56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.24711","article-title":"Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the","volume":"23","author":"Jung","year":"2017","journal-title":"Internat. Liver Transplantation Soc."},{"issue":"41","key":"10.1016\/j.ejso.2023.107279_bib57","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.3748\/wjg.v27.i41.7173","article-title":"Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma","volume":"27","author":"Tang","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.ejso.2023.107279_bib58","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1007\/s00330-020-06861-2","article-title":"Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?","volume":"30","author":"Wang","year":"2020","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107279_bib59","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/gastro\/goaa003","article-title":"Long-term outcome and prognostic factors of combined hepatocellular carcinoma and cholangiocarcinoma after curative resection","volume":"8","author":"Jiang","year":"2020","journal-title":"Gastroenterology report"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12957-019-1586-8","article-title":"Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends","volume":"17","author":"Wang","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib61","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/cncr.10384","article-title":"Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients","volume":"94","author":"Leung","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib62","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1200\/JCO.2013.53.7746","article-title":"SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma","volume":"33","author":"Zhu","year":"2015","journal-title":"J\u00a0Clin Oncol : Offi J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107279_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000171490","article-title":"Hepatocellular carcinoma: update on diagnosis and treatment","volume":"13","author":"Ramsey","year":"1995","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0106-9543.2001.01580.x","article-title":"The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin","volume":"22","author":"Asayama","year":"2002","journal-title":"Liver"},{"issue":"3","key":"10.1016\/j.ejso.2023.107279_bib65","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/1097-0142(19930801)72:3<683::AID-CNCR2820720310>3.0.CO;2-C","article-title":"Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan","volume":"72","author":"Tomimatsu","year":"1993","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2023.107279_bib66","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.gassur.2006.01.018","article-title":"Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma","volume":"10","author":"Tang","year":"2006","journal-title":"J\u00a0Gastrointest Surg : official J Soc Surg Alimentary Tract"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib67","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00534-006-1117-1","article-title":"Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population","volume":"13","author":"Chantajitr","year":"2006","journal-title":"J\u00a0Hepato-Biliary-Pancreatic Surg"},{"issue":"12","key":"10.1016\/j.ejso.2023.107279_bib68","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1007\/s11605-019-04140-0","article-title":"Nomogram to assist in surgical plan for hepatocellular carcinoma: a prediction model for microvascular invasion","volume":"23","author":"Lin","year":"2019","journal-title":"J\u00a0Gastrointest Surg : official J Soc Surg Alimentary Tract"},{"issue":"4","key":"10.1016\/j.ejso.2023.107279_bib69","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s11605-019-04134-y","article-title":"A\u00a0clinical scoring system for predicting microvascular invasion in patients with hepatocellular carcinoma within the milan criteria","volume":"23","author":"Ryu","year":"2019","journal-title":"J\u00a0Gastrointest Surg : official J Soc Surg Alimentary Tract"},{"issue":"22","key":"10.1016\/j.ejso.2023.107279_bib70","first-page":"5575","article-title":"Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma","volume":"10","author":"Tang","year":"2019","journal-title":"J\u00a0Cancer"},{"issue":"15","key":"10.1016\/j.ejso.2023.107279_bib71","doi-asserted-by":"crossref","first-page":"15334","DOI":"10.18632\/aging.103577","article-title":"Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"issue":"11","key":"10.1016\/j.ejso.2023.107279_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112722","article-title":"Non-invasive biomarkers for earlier detection of pancreatic cancer-A comprehensive review","volume":"13","author":"Brezgyte","year":"2021","journal-title":"Cancers"},{"issue":"13","key":"10.1016\/j.ejso.2023.107279_bib73","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3748\/wjg.v24.i13.1451","article-title":"Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients","volume":"24","author":"Xu","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.ejso.2023.107279_bib74","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/liv.14763","article-title":"Machine-learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection","volume":"41","author":"Qin","year":"2021","journal-title":"Liver Int : Offi J Int Assoc Study Liver"},{"issue":"8","key":"10.1016\/j.ejso.2023.107279_bib75","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1245\/s10434-020-08350-8","article-title":"The impact of preoperative CA19-9 and CEA on outcomes of patients with intrahepatic cholangiocarcinoma","volume":"27","author":"Moro","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107279_bib76","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6016931","article-title":"Clinical significance of preoperative serum CEA, CA125, and CA19-9 levels in predicting the resectability of cholangiocarcinoma","volume":"2019","author":"Fang","year":"2019","journal-title":"Dis Markers"},{"issue":"3","key":"10.1016\/j.ejso.2023.107279_bib77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.ejso.2023.107279_bib78","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/MEG.0b013e3283625df9","article-title":"Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases","volume":"26","author":"Chu","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib79","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12876-020-01586-4","article-title":"Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib80","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjsurg.2004.03.018","article-title":"Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma","volume":"189","author":"Koh","year":"2005","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib81","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.rct.0000235072.34808.9b","article-title":"Recurrence patterns of combined hepatocellular-cholangiocarcinoma on enhanced computed tomography","volume":"31","author":"Shin","year":"2007","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"3","key":"10.1016\/j.ejso.2023.107279_bib82","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.04.024","article-title":"Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma","volume":"67","author":"Lee","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107279_bib83","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0000000000003268","article-title":"Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation","volume":"273","author":"Lee","year":"2021","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ejso.2023.107279_bib84","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/cncr.10392","article-title":"Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors","volume":"94","author":"Jarnagin","year":"2002","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib85","doi-asserted-by":"crossref","first-page":"e1187","DOI":"10.1097\/SLA.0000000000003788","article-title":"Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis","volume":"274","author":"Zhang","year":"2021","journal-title":"Ann Surg"},{"issue":"14","key":"10.1016\/j.ejso.2023.107279_bib86","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1158\/1078-0432.CCR-21-0412","article-title":"Intrahepatic cholangiocarcinoma with lymph node metastasis: treatment-related outcomes and the role of tumor genomics in patient selection","volume":"27","author":"Jolissaint","year":"2021","journal-title":"Clin Cancer Res : Offi J Am Assoc Cancer Res"},{"issue":"9","key":"10.1016\/j.ejso.2023.107279_bib87","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrclinonc.2014.122","article-title":"Treatment of intermediate-stage hepatocellular carcinoma","volume":"11","author":"Forner","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2023.107279_bib88","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ejso.2022.01.009","article-title":"The effect of trans arterial chemoembolization in the management of intrahepatic cholangiocarcinoma. A systematic review and meta-analysis","volume":"48","author":"Lv","year":"2022","journal-title":"Eur J Surg Oncol : J. European Soc. Surgical Oncology British Assoc. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ejso.2023.107279_bib89","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1148\/radiol.09091076","article-title":"Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization","volume":"255","author":"Kim","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.ejso.2023.107279_bib90","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/CMAR.S288522","article-title":"Prognostic value of sarcopenia and systemic inflammation markers in patients undergoing definitive radiotherapy for esophageal cancer","volume":"13","author":"Liang","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"8","key":"10.1016\/j.ejso.2023.107279_bib91","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1245\/s10434-014-4281-6","article-title":"Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer","volume":"22","author":"Miyamoto","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2023.107279_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081888","article-title":"Total psoas area and total muscular parietal area affect long-term survival of patients undergoing pneumonectomy for non-small cell lung cancer","volume":"13","author":"Daffr\u00e8","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.ejso.2023.107279_bib93","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.surg.2015.02.002","article-title":"Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer","volume":"157","author":"Okumura","year":"2015","journal-title":"Surgery"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323009174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323009174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:49:49Z","timestamp":1760060989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323009174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0748798323009174"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107279","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of prognostic factors for overall survival and disease-free survival among resected patients with combined hepatocellular carcinoma and cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107279"}}